Mobile

AN OPEN LABEL EXTENSION STUDY TO INVESTIGATE THE LONG TERM SAFETY, TOLERABILITY AND EFFICACY OF PF-02545920 IN SUBJECTS WITH HUNTINGTON’S DISEASE WHO PREVIOUSLY COMPLETED STUDY A8241021

Mise à jour : Il y a 4 ans
Référence : U1111-1162-4293

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

- To assess long-term safety and tolerability of 20 mg BID of PF-02545920 in subjects with HD.

Critère d'inclusion

  • Huntington's disease

Liens